Response to type 2 deiodinase Thr92Ala polymorphism is not associated with arterial hypertension in type 2 diabetes mellitus patients [12]

Hypertension

Volumn 49, Issue 6, 2007, Pages

  Gumieniak, Olga ^a   Williams, Gordon H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; TYPE 2 DEIODINASE; UNCLASSIFIED DRUG;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; COMORBIDITY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HEREDITY; HORMONE SUBSTITUTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34249339078     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.088559     Document Type: Letter

References (6)

1. Canani LH, Leie MA, Machado WE, Capp C, Maia AL. Type 2 deiodinase Thr92Ala polymorphism is not associated with arterial hypertension in type 2 diabetes mellitus patients. Hypertension. 2007;49:e47.
2. Gumieniak O, Perlstein TS, Williams JS, Hopkins PN, Brown NJ, Raby BA, Williams GH. Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension. 2007;49:461-466.
3. Williams GH. Genetic factors associated with volume-sensitive hypertension. Mol Cell Endocrinol. 2004;217:41-44.
4. Lalouel J. Large-scale search for genes predisposing to essential hypertension. Am J Hypertens. 2003;16:163-166.
5. Kosachunhanun N, Hunt SC, Hopkins PN, Williams RR, Jeunemaitre X, Corvol P, Ferri C, Mortensen RM, Hollenberg NK, Williams GH. Genetic determinants of nonmodulating hypertension. Hypertension. 2003;42:901-908.
6. Freeman H, Cox RD. Type-2 diabetes: a cocktail of genetic discovery. Human Molecular Genetics. 2006;15:R202-R209.